Lataa...
Mechanisms of Resistance to Immune Checkpoint Blockade
The recent development of effective immune checkpoint inhibition (ICI), first demonstrated in melanoma, has revolutionized cancer treatment. Monoclonal antibodies blocking the immune checkpoints cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) and programmed death 1 receptor (PD-1) have shown su...
Tallennettuna:
| Julkaisussa: | Am J Clin Dermatol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358473/ https://ncbi.nlm.nih.gov/pubmed/30259383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-018-0389-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|